In silico prediction of drug permeability across buccal mucosa

Pharmaceutical Research

Volumn 26, Issue 5, 2009, Pages 1130-1139

  Kokate, Amit ^a   Li, Xiaoling ^a   Williams, Paul J ^a   Singh, Parminder ^b   Jasti, Bhaskara R ^a  

^a UNIVERSITY OF THE PACIFIC   (United States)

^b Corium International ^*  (United States)

Author keywords

Buccal; In silico; Permeability; Prediction

Indexed keywords

AMITRIPTYLINE; ATENOLOL; BUPIVACAINE; CAFFEINE; DILTIAZEM; FUROSEMIDE; LIDOCAINE; METOPROLOL; NAPROXEN; NIMESULIDE; PHENAZONE; PINDOLOL; PROPRANOLOL; VERAPAMIL; WARFARIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHEEK MUCOSA; COMPUTER MODEL; DRUG PENETRATION; DRUG STRUCTURE; HYDROGEN BOND; MULTIPLE LINEAR REGRESSION ANALYSIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SWINE;

ADMINISTRATION, BUCCAL; ANIMALS; LINEAR MODELS; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; MOUTH MUCOSA; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; PREDICTIVE VALUE OF TESTS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SOLUBILITY; SWINE;

EID: 63949085325     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-9831-4     Document Type: Article

References (56)

1. M. Rathbone B. Drummond I. Tucker 1994 The oral cavity as a site for systemic drug delivery Adv. Drug Del. Rev 13 1 22 doi:10.1016/0169-409X(94) 90024-8
2. W. R. Galey H. K. Lonsdale S. Nacht 1976 The in vitro permeability of skin and buccal mucosa to selected drugs and tritiated water J. Invest. Dermatol 67 713 717 doi:10.1111/1523-1747.ep12598596
3. C. A. Squier P. W. Wertz 1993 Permeability and pathophysiology of oral mucosa Adv Drug Deliv Rev 12 13 24 doi:10.1016/0169-409X(93)90038-6
4. A. Kokate, V. Marasanapalle, B. R. Jasti, and X. Li. Physiological and biochemical barriers to drug delivery. In B. R. Jasti (ed.), Design of controlled release drug delivery systems, McGraw-Hill, New York, 2006, p. 41.
5. P. P. H. Le Brun P. L. A. Fox M. E. de Vries H. E. Bodde 1989 In vitro penetration of some β-adrenoreceptor blocking drugs through porcine buccal mucosa Int. J. Pharm 49 141 145 doi:10.1016/0378-5173(89)90113-0
6. Y. Sudhakar K. Kuotsu A. K. Bandyopadhyay 2006 Buccal bioadhesive drug delivery-a promising option for orally less efficient drugs J. Control. Release 114 15 40 doi:10.1016/j.jconrel.2006.04.012
7. C. A. Squier P. Cox P. W. Wertz 1991 Lipid content and water permeability of skin and oral mucosa J. Invest. Dermatol 96 123 126 doi:10.1111/1523-1747. ep12515931
8. P. W. Wertz C. A. Squier 1991 Cellular and molecular basis of barrier function in oral epithelium Crit. Rev. Ther. Drug Carrier Syst 8 237 269
9. C. A. Lesch C. A. Squier A. Cruchley D. M. Williams P. Speight 1989 The permeability of human oral mucosa and skin to water J. Dent. Res 68 1345 1349
10. R.O. Potts R.H. Guy 1992 Predicting skin permeability Pharm. Res 9 663 669 doi:10.1023/A:1015810312465
11. A. Malkia L. Murtomaki A. Urtti K. Kontturi 2004 Drug permeation in biomembranes: in vitro and in silico prediction and influence of physicochemical properties Eur. J. Pharm. Sci 23 13 47 doi:10.1016/j.ejps.2004.05.009
12. Molinspiration. http://www.molinspiration.com (2007).
13. P. Ertl B. Rohde P. Selzer 2000 Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties J. Med. Chem 43 3714 3717 doi:10.1021/jm000942e
14. D. F. Veber S. R. Johnson H. Y. Cheng B. R. Smith K. W. Ward K. D. Kopple 2002 Molecular properties that influence the oral bioavailability of drug candidates J. Med. Chem 45 2615 2623 doi:10.1021/jm020017n
15. C. A. Bergstrom K. Luthman P. Artursson 2004 Accuracy of calculated pH-dependent aqueous drug solubility Eur. J. Pharm. Sci 22 387 398 doi:10.1016/j.ejps.2004.04.006
16. ChemIDplus. http://chem.sis.nlm.nih.gov/chemidplus/ (2007).
17. J. Hadgraft C. Valenta 2000 pH, pK(a) and dermal delivery Int. J. Pharm 200 243 247 doi:10.1016/S0378-5173(00)00402-6
18. K. Fredholt D. H. Larsen C. Larsen 2000 Modification of in vitro drug release rate from oily parenteral depots using a formulation approach Eur. J. Pharm. Sci 11 231 237 doi:10.1016/S0928-0987(00)00104-4
19. B. A. Hendriksen M. V. Felix M. B. Bolger 2003 The composite solubility versus pH profile and its role in intestinal absorption prediction AAPS Pharm. Sci 5 E4 doi:10.1208/ps050104
20. J. Jacobsen B. Van deurs M. Pedersen M. R. Rassing 1995 TR146 cells grown on filters as a model for human buccal epithelium: I. Morphology, growth, barrier properties, and permeability Int. J. Pharm 125 165 184 doi:10.1016/0378-5173(95)00109-V
21. A. Avdeef P. Artursson S. Neuhoff L. Lazorova J. Grasjo S. Tavelin 2005 Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method Eur. J. Pharm. Sci 24 333 349 doi:10.1016/j.ejps.2004.11.011
22. ACD, Re-evaluation of logP data for 22 drugs and comparison of 6 calculation methods, in: (ACD Labs, 2006).
23. F. Yoshida J. G. Topliss 2000 QSAR model for drug human oral bioavailability J. Med. Chem 43 2575 2585 doi:10.1021/jm0000564
24. P. Modamio C. F. Lastra E. L. Marino 2000 A comparative in vitro study of percutaneous penetration of beta-blockers in human skin Int. J. Pharm 194 249 259 doi:10.1016/S0378-5173(99)00380-4
25. P. R. B. Fallavena E. E. S. Schapoval 1997 pKa determination of nimesulide in methanol-water mixtures by potentiometric titrations Int. J. Pharm 158 109 112 doi:10.1016/S0378-5173(97)00221-4
26. F. Akomeah T. Nazir G. P. Martin M. B. Brown 2004 Effect of heat on the percutaneous absorption and skin retention of three model penetrants Eur. J. Pharm. Sci 21 337 345 doi:10.1016/j.ejps.2003.10.025
27. K. Higaki M. Asai T. Suyama K. Nakayama K. Ogawara T. Kimura 2002 Estimation of intradermal disposition kinetics of drugs: II. Factors determining penetration of drugs from viable skin to muscular layer Int. J. Pharm 239 129 141 doi:10.1016/S0378-5173(02)00084-4
28. Merck. Merck Index, New Jersey, 1976.
29. R. Birudaraj B. Berner S. Shen X. Li 2005 Buccal permeation of buspirone: mechanistic studies on transport pathways J Pharm Sci 94 70 78 doi:10.1002/jps.20208
30. S. Geinoz R. H. Guy B. Testa P. A. Carrupt 2004 Quantitative structure-permeation relationships (QSPeRs) to predict skin permeation: a critical evaluation Pharm. Res 21 83 92 doi:10.1023/B:PHAM.0000012155.27488.2b
31. NCSS. User's Guide: Regression and curve fitting, NCCS, Kaysville, Utah, 2006.
32. C. A. Bergstrom C. M. Wassvik U. Norinder K. Luthman P. Artursson 2004 Global and local computational models for aqueous solubility prediction of drug-like molecules J. Chem. Inf. Comput. Sci 44 1477 1488 doi:10.1021/ci049909h
33. P. W. Wertz D. C. Swartzendruber C. A. Squier 1993 Regional variation in the structure and permeability of oral mucosa and skin Adv. Drug Deliv. Rev 12 1 12 doi:10.1016/0169-409X(93)90037-5
34. A. Kokate X. Li P. Singh B. R. Jasti 2008 Effect of thermodynamic activities of the unionized and ionized species on drug flux across buccal mucosa J. Pharm. Sci 97 4294 4306 doi:10.1002/jps.21301
35. P. Artursson K. Palm K. Luthman 2001 Caco-2 monolayers in experimental and theoretical predictions of drug transport Adv. Drug Deliv. Rev 46 27 43 doi:10.1016/S0169-409X(00)00128-9
36. T. J. Hou W. Zhang K. Xia X. B. Qiao X. J. Xu 2004 ADME evaluation in drug discovery. 5. Correlation of Caco-2 permeation with simple molecular properties J. Chem. Inf. Comput. Sci 44 1585 1600 doi:10.1021/ci049884m
37. M. J. Campbell. Statistics at square two: Understanding modern statistical applications in medicine. BML Publishing Group, London, 2001.
38. I. Jae Myung 2003 Tutorial on maximum likelihood estimation J. Math. Psychol 47 90 100 doi:10.1016/S0022-2496(02)00028-7
39. J. Linnankoski J. M. Makela V. P. Ranta A. Urtti M. Yliperttula 2006 Computational prediction of oral drug absorption based on absorption rate constants in humans J. Med. Chem 49 3674 3681 doi:10.1021/jm051231p
40. S. Winiwarter N. M. Bonham F. Ax A. Hallberg H. Lennernas A. Karlen 1998 Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach J. Med. Chem 41 4939 4949 doi:10.1021/jm9810102
41. N. el Tayar R. S. Tsai B. Testa P. A. Carrupt A. Leo 1991 Partitioning of solutes in different solvent systems: the contribution of hydrogen-bonding capacity and polarity J. Pharm. Sci 80 590 598 doi:10.1002/jps.2600800619
42. R. A. Conradi A. R. Hilgers N. F. Ho P. S. Burton 1992 The influence of peptide structure on transport across Caco-2 cells. II. Peptide bond modification which results in improved permeability Pharm. Res 9 435 439 doi:10.1023/A:1015867608405
43. I. Diaz Del Consuelo G. P. Pizzolato F. Falson R. H. Guy Y. Jacques 2005 Evaluation of pig esophageal mucosa as a permeability barrier model for buccal tissue J. Pharm. Sci 94 2777 2788 doi:10.1002/jps.20409
44. J. Xiang X. Fang X. Li 2002 Transbuccal delivery of 2′,3′- dideoxycytidine: in vitro permeation study and histological investigation Int. J. Pharm 231 57 66 doi:10.1016/S0378-5173(01)00865-1
45. A. H. Shojaei M. Khan G. Lim R. Khosravan 1999 Transbuccal permeation of a nucleoside analog, dideoxycytidine: effects of menthol as a permeation enhancer Int. J. Pharm 192 139 146 doi:10.1016/S0378-5173(99)00301-4
46. V. H. Deneer G. B. Drese P. E. Roemele J. C. Verhoef A. H. L. Lie J. H. Kingma J. R. Brouwers H. E. Junginger 2002 Buccal transport of flecainide and sotalol: effect of a bile salt and ionization state Int. J. Pharm 241 127 134 doi:10.1016/S0378-5173(02)00229-6
47. M. Artusi P. Santi P. Colombo H. E. Junginger 2003 Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studies Int. J. Pharm 250 203 213 doi:10.1016/S0378-5173(02)00545-8
48. S. Senel D. Duchene A. A. Hincal Y. Capan G. Ponchel 1998 In vitro studies on enhancing effect of sodium glycocholate on transbuccal permeation of morphine hydrochloride J. Control. Release 51 107 113 doi:10.1016/S0168-3659(97) 00099-0
49. H. M. Nielsen M. R. Rassing 2002 Nicotine permeability across the buccal TR146 cell culture model and porcine buccal mucosa in vitro: effect of pH and concentration Eur. J. Pharm. Sci 16 151 157 doi:10.1016/S0928-0987(02)00083-0
50. J. A. Nicolazzo B. L. Reed B. C. Finnin 2004 Modification of buccal drug delivery following pretreatment with skin penetration enhancers J. Pharm. Sci 93 2054 2063 doi:10.1002/jps.20113
51. H. M. Nielsen M. R. Rassing 2000 TR146 cells grown on filters as a model of human buccal epithelium: IV. Permeability of water, mannitol, testosterone and beta-adrenoceptor antagonists. Comparison to human, monkey and porcine buccal mucosa Int. J. Pharm 194 155 167 doi:10.1016/S0378-5173(99)00368-3
52. C. A. Squier 1986 Penetration of nicotine and nitrosonornicotine across porcine oral mucosa J. Appl. Toxicol 6 123 128 doi:10.1002/jat.2550060211
53. C. L. Adrian H. B. Olin K. Dalhoff J. Jacobsen 2006 In vivo human buccal permeability of nicotine Int. J. Pharm 311 196 202 doi:10.1016/j.ijpharm.2005. 12.039
54. M. T. Cronin J. C. Dearden G. P. Moss G. Murray-Dickson 1999 Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationships Eur. J. Pharm. Sci 7 325 330 doi:10.1016/S0928-0987(98)00041-4
55. H. Patel W. ten Berge M. T. Cronin 2002 Quantitative structure-activity relationships (QSARs) for the prediction of skin permeation of exogenous chemicals Chemosphere 48 603 613 doi:10.1016/S0045-6535(02)00114-5
56. F. Faassen J. Kelder J. Lenders R. Onderwater H. Vromans 2003 Physicochemical properties and transport of steroids across Caco-2 cells Pharm. Res 20 177 186 doi:10.1023/A:1022210801734